Elite Pharmaceuticals director Barry H. Dash reports acquisition of $25,980 in common shares
ELTP•Director Barry H. Dash purchased 100,000 Elite Pharmaceuticals common shares at $0.2598 each, raising his direct beneficial ownership to 3,365,555 shares.
1. Share purchase
Barry H. Dash, a director of Elite Pharmaceuticals, purchased 100,000 common shares at $0.2598 each. His direct beneficial ownership rose to 3,365,555 common shares.
